Related Experiment Video

Updated: Jul 14, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Platelet glycoprotein IIb HPA-3 polymorphism and acute coronary syndromes

John Lekakis1, Sofia Bisti, Elias Tsougos

  • 1Department of Cardiology, Attikon University Hospital, Athens University, Greece. lekakis@tellas.gr

International Journal of Cardiology
|June 15, 2007
PubMed

Insights

Platelet GPIIb/IIIa receptor polymorphisms, specifically the HPA-3b allele, are linked to a higher risk of ST-segment elevation myocardial infarction (STEMI). HPA-3 genotypes do not predict future cardiovascular events in coronary artery disease patients.

Area of Science:

  • Cardiovascular Genetics
  • Hematology
  • Molecular Biology

Background:

  • Platelet GPIIb/IIIa receptor polymorphisms are of significant research interest in coronary artery disease (CAD).
  • Understanding these genetic variations may offer insights into disease mechanisms and patient stratification.

Purpose of the Study:

  • To investigate the association between HPA-3 (GPIIb subunit) polymorphisms and the extent of coronary thrombosis in CAD patients.
  • To compare the frequency of HPA-3 alleles between patients with ST-segment elevation myocardial infarction (STEMI) and those with less extensive coronary thrombosis (NSTEMI, UA, chronic CAD).

Main Methods:

  • Genotyping for the HPA-3 (a and b alleles) polymorphism was performed in 118 CAD patients and 15 healthy controls.
  • Patients were categorized based on the severity of coronary thrombosis: STEMI, NSTEMI/unstable angina (UA), and chronic CAD.
  • Follow-up for 21 months assessed the occurrence of death, myocardial infarction, and revascularization.

Main Results:

  • A significantly higher frequency of HPA-3b homozygosity was observed in STEMI patients (45%) compared to NSTEMI-UA (10%), chronic CAD (22%), and healthy controls (13%).
  • HPA-3b homozygosity conferred a 5-fold increased risk for STEMI compared to other genotypes, even after adjusting for risk factors (OR: 5.90, p=0.01).
  • No association was found between HPA-3 genotypes and cardiovascular events during the follow-up period.

Conclusions:

  • HPA-3b homozygous individuals show a predisposition towards developing STEMI rather than NSTEMI or UA within acute coronary syndrome patients.
  • The HPA-3 genotypes are not predictive of future cardiovascular events in patients with established CAD.
Abstract

More Related Videos

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Ferric Chloride-induced Murine Thrombosis Models10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...